BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8089668)

  • 1. Effects of vigabatrin on partial seizures and cognitive function.
    Grünewald RA; Thompson PJ; Corcoran R; Corden Z; Jackson GD; Duncan JS
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1057-63. PubMed ID: 8089668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.
    Brodie MJ; Mumford JP
    Epilepsy Res; 1999 Apr; 34(2-3):199-205. PubMed ID: 10210035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA; Dumas C; Ghirardi L
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.
    French JA; Mosier M; Walker S; Sommerville K; Sussman N
    Neurology; 1996 Jan; 46(1):54-61. PubMed ID: 8559421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
    Chadwick D
    Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
    Dalla Bernardina B; Fontana E; Vigevano F; Fusco L; Torelli D; Galeone D; Buti D; Cianchetti C; Gnanasakthy A; Iudice A
    Epilepsia; 1995 Jul; 36(7):687-91. PubMed ID: 7555986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between vigabatrin and impaired cognition.
    Monaco F; Torta R; Cicolin A; Borio R; Varetto A; Bergamasco L; Vighetti S
    J Int Med Res; 1997; 25(5):296-301. PubMed ID: 9364292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.
    Guberman A; Bruni J
    Seizure; 2000 Mar; 9(2):112-8. PubMed ID: 10845734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin withdrawal randomized study in children.
    Chiron C; Dulac O; Gram L
    Epilepsy Res; 1996 Nov; 25(3):209-15. PubMed ID: 8956918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
    Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and cognitive effects of vigabatrin.
    Ylinen A; Kälviäinen R; Riekkinen PJ
    Acta Neurol Scand Suppl; 1995; 162():47-50. PubMed ID: 7495191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
    Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
    Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
    Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial.
    Coppola G; Terraciano AM; Pascotto A
    Brain Dev; 1997 Nov; 19(7):459-63. PubMed ID: 9408591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.
    Dean C; Mosier M; Penry K
    Epilepsia; 1999 Jan; 40(1):74-82. PubMed ID: 9924905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.